BioCentury
ARTICLE | Company News

Synterys, VistaGen deal

December 12, 2011 8:00 AM UTC

VistaGen partnered with drug discovery services company Synterys to develop stem cell-based drug rescue variants of preclinical products previously discontinued by drug developers due to toxicity issu...